Abstract
Rheumatoid arthritis (RA), a prototypical immune-mediated inflammatory disease, is characterized by increased cardiovascular morbidity and mortality, independent from the established cardiovascular risk factors. The chronic inflammatory state, a hallmark of RA, is considered to be a driving force for accelerated atherogenesis. Concurrent conditions that expedite the atherosclerotic process in RA involve endothelial dysfunction, dyslipidemia and procoagulant changes. These facilitating states can be reversed by retraction of the systemic inflammatory activity. Consequently, aggressive control of disease activity has been suggested to be instrumental for cardiovascular risk reduction. In the present review, we focus on these critical determinant that promote premature atherosclerosis in RA.
Keywords: Atheroslerosis, rheumatoid arthritis, cardiovascular risk factors, chronic inflammation, human cancers, pathogenesis, skin carcinogenesis, hydroxytyrosol, tyrosol, Hydroxytyrosol (3,4 DHPEA-EDA), HL60 (human promyelocytic leukemia cells), caspases, poly-ADP-ribose polym-erase, cytochrome, cytosolic proteins, Her-2/neu, Her2/neu on-cogene, cellular proliferation, transformation, differentiation, mo-tility, metastasis, p185 Her-2/neu oncoprotein, BT-474, SK-Br3 cells, trastuzumab (Her-ceptinTM), Akt, PI-3 kinase/Akt pathway, erythrodiol, pentacyclic triterpenic acids, Olea Euopaea, HT-29 cells, reactive oxygen species, Confocal micros-copy analysis, squalene, cholesterol biosynthesis, Ras farnesylation, MAPK pathway, Bcl-2 pathways, Apaf 1, apoptosome, necrotic cells, Caiazzana and Ravece, colorectal can-cer cell lines, ATM-p53, pinoresinol, oleocanthal, Bcl-2 family, Bax, trol of the G2/M checkpoint, p53 is directly controlled by the ATM-ATR genes
Current Pharmaceutical Design
Title: Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis
Volume: 17 Issue: 1
Author(s): R. J. Bisoendial, E. S.G. Stroes and P. P. Tak
Affiliation:
Keywords: Atheroslerosis, rheumatoid arthritis, cardiovascular risk factors, chronic inflammation, human cancers, pathogenesis, skin carcinogenesis, hydroxytyrosol, tyrosol, Hydroxytyrosol (3,4 DHPEA-EDA), HL60 (human promyelocytic leukemia cells), caspases, poly-ADP-ribose polym-erase, cytochrome, cytosolic proteins, Her-2/neu, Her2/neu on-cogene, cellular proliferation, transformation, differentiation, mo-tility, metastasis, p185 Her-2/neu oncoprotein, BT-474, SK-Br3 cells, trastuzumab (Her-ceptinTM), Akt, PI-3 kinase/Akt pathway, erythrodiol, pentacyclic triterpenic acids, Olea Euopaea, HT-29 cells, reactive oxygen species, Confocal micros-copy analysis, squalene, cholesterol biosynthesis, Ras farnesylation, MAPK pathway, Bcl-2 pathways, Apaf 1, apoptosome, necrotic cells, Caiazzana and Ravece, colorectal can-cer cell lines, ATM-p53, pinoresinol, oleocanthal, Bcl-2 family, Bax, trol of the G2/M checkpoint, p53 is directly controlled by the ATM-ATR genes
Abstract: Rheumatoid arthritis (RA), a prototypical immune-mediated inflammatory disease, is characterized by increased cardiovascular morbidity and mortality, independent from the established cardiovascular risk factors. The chronic inflammatory state, a hallmark of RA, is considered to be a driving force for accelerated atherogenesis. Concurrent conditions that expedite the atherosclerotic process in RA involve endothelial dysfunction, dyslipidemia and procoagulant changes. These facilitating states can be reversed by retraction of the systemic inflammatory activity. Consequently, aggressive control of disease activity has been suggested to be instrumental for cardiovascular risk reduction. In the present review, we focus on these critical determinant that promote premature atherosclerosis in RA.
Export Options
About this article
Cite this article as:
J. Bisoendial R., S.G. Stroes E. and P. Tak P., Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis, Current Pharmaceutical Design 2011; 17 (1) . https://dx.doi.org/10.2174/138161211795049741
DOI https://dx.doi.org/10.2174/138161211795049741 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
(Iso)Flav(an)ones, Chalcones, Catechins, and Theaflavins as Anticarcinogens: Mechanisms, Anti-Multidrug Resistance and QSAR Studies
Current Medicinal Chemistry Subject Index to Volume 3
Mini-Reviews in Medicinal Chemistry Current Status of Complementary and Alternative Medicine in the Treatment of Rheumatic Disease Pain
Current Rheumatology Reviews The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease
Current Medicinal Chemistry Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam
Current Drug Delivery A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory Arthritis
Current Rheumatology Reviews The Metabolism and Disposition of Koumine, Gelsemine and Humantenmine from Gelsemium
Current Drug Metabolism COX-Inhibiting Nitric Oxide Donors (CINODs): Potential Benefits on Cardiovascular and Renal Function
Cardiovascular & Hematological Agents in Medicinal Chemistry A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
Current Pharmaceutical Design Modifiers of Hearing Impairment in Humans and Mice
Current Genomics Interstitial Lung Disease in Rheumatoid Arthritis
Current Rheumatology Reviews Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Measures in Musculoskeletal Ultrasound. What are Valid?
Current Rheumatology Reviews Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology Linking Inflammation to Cell Cycle Progression
Current Pharmaceutical Design Ex-ante Evaluation of Biotechnology Innovations: the Case of Folate Biofortified Rice in China
Current Pharmaceutical Biotechnology Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy
Mini-Reviews in Medicinal Chemistry Structure-based Design of Mimetics for Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)
Current Pharmaceutical Design Emerging Cytokines in Allergic Airway Inflammation: A Genetic Update
Current Immunology Reviews (Discontinued)